Welcome to the 3rd Microbiome Movement – Drug Development Summit Europe 2019
Despite the scientific communities’ continuing progress in translating microbiome R&D into promising therapeutic candidates across critical disease phenotypes, the pharmaceutical community continue to identify the causal role of the human microbiome in disease to create effective treatments with consistent clinical outcomes.
Part of the established Microbiome Movement, the 3rd Microbiome Movement – Drug Development Europe 2019 returns as the world’s only case study driven, end-to-end meeting which focuses exclusively on the discovery, development and commercialization of microbiome-based therapeutics; making it the industry-leading forum for drug developers.
2nd Microbiome Movement – Drug Development Summit Europe 2018 Highlights
PART OF THE MICROBIOME MOVEMENT SERIES